VERADIGM INC (MDRX)
(Delayed Data from OTC)
$7.96 USD
+0.01 (0.13%)
Updated Apr 26, 2024 03:59 PM ET
3-Hold of 5 3
A Value D Growth F Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
MDRX 7.96 +0.01(0.13%)
Will MDRX be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for MDRX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MDRX
Veradigm (MDRX) to Acquire AI Service Provider ScienceIO
Veradigm (MDRX) & MedAllies Partner for Better Care Decisions
MDRX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Veradigm's (MDRX) Acquires Koha Health to Solidify Market Presence
Braze, Inc. (BRZE) Reports Q3 Loss, Tops Revenue Estimates
Veradigm's (MDRX) New Offering to Enhance Patient Engagement
Other News for MDRX
Teramind Announces Formation of Insider Risk Executive Advisory Board
Veradigm Network Solution Practice Fusion EHR Receives Top Ambulatory Rankings
Veradigm announces strategic collaboration with Vim
Veradigm just downgraded at Deutsche Bank, here's why
Veradigm’s Challenging Outlook: Hold Rating Justified Amid Revenue Growth, Margin Pressures, and Audit Concerns